ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1233 • 2014 ACR/ARHP Annual Meeting

    Tocilizumab (TCZ) in the Treatment of AA Amyloidosis in Patients with Familial Mediterranean Fever

    Huri Ozdogan, Serdal Ugurlu, Aysa Hacioglu, Yasaman Adibnia and Vedat Hamuryudan, Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey

    Background/Purpose: AA amyloidosis is the major long-term complication of various chronic inflammatory diseases like rheumatoid arthritis, ankylosing spondylitis, FMF and other autoinflammatory syndromes. Treatment of…
  • Abstract Number: 1232 • 2014 ACR/ARHP Annual Meeting

    Canakinumab Therapy in Patients with Familial Mediterranean Fever

    Serdal Ugurlu, Emire Seyahi, Gulen Hatemi, Aysa Hacioglu, Fatma Nihan Akkoc and Huri Ozdogan, Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey

    Background/Purpose: According to a recent pilot study Canakinumab reduced the frequency of attacks in 9 patients with Familial Mediterranean Fever (FMF) resistant to colchicine with no…
  • Abstract Number: 1231 • 2014 ACR/ARHP Annual Meeting

    Evidence Based Recommendations for Genetic Diagnosis of Familial Mediterranean Fever

    Gabriella Giancane1, Nienke ter Haar2, Nico Wulffraat3, Bas Vastert4, Karyl Barron5, Veronique Hentgen6, Tilmann Kallinich7, Huri Ozdogan8, Jordi Anton9, Paul Brogan10, Luca Cantarini11, Joost Frenkel4, Caroline Galeotti12, Marco Gattorno13, Gilles Grateau14, Michael Hofer15, Isabelle Kone-Paut16, J B. Kuemmerle-Deschner17, Helen Lachmann18, Anna Simon19, Brian Feldman20, Yosef Uziel21 and Seza Ozen22, 1Pediatric Immunology, UMC, Utrecht, Netherlands, Utrecht, Netherlands, 2Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Pediatric rheumatology, Wilhelmina Children's Hospital/ UMC Utrecht, Utrecht, Netherlands, 4University Medical Center Utrecht, Utrecht, Netherlands, 5NIH, Bethesda, MD, 6Versailles Hospital, Le Chesnay Cedex, France, 7Charite, University Medicine Berlin, Berlin, Germany, 8Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 9Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, 10Rheumatology Unit, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 11University of Siena, Siena, Italy, 12Bicêtre Hospital, University of Paris SUD, Paris, France, 13Istituto Giannina Gaslini, Genova, Italy, 14Service De Médecine Interne, Hopital Tenon, Paris, France, 15Centre Multisite Romand de Rhumatologie Pediatrique, Lausanne, Switzerland, 16Department of Pediatric Rheumatology, Reference Centre for Autoinflammatory Disorders CEREMAI, Bicêtre Hospital, University of Paris SUD, Paris, France, 17Division of Pediatric Rheumatology, Department of Pediatrics, University Hospital Tuebingen, Tuebingen, Germany, 18UK National Amyloidosis Centre, University College London Medical School, London, United Kingdom, 19Radboudumc, Nijmegen, Netherlands, 20Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 21Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel, 22Deptartment. of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey

    Background/Purpose: Familial Mediterranean Fever (FMF) is a disease that starts in childhood and can lead to significant morbidity. In 2013, an initiative called SHARE (Single…
  • Abstract Number: 1230 • 2014 ACR/ARHP Annual Meeting

    Efficacy of Interleukin-1 Targeting Drugs in Familial Mediterranean Fever Patients

    Pinar Cetin1, Ismail Sari1, Betul Sozeri2, Ozlem Cam2, Merih Birlik1, Fatos Onen1, Nurullah Akkoc1 and Servet Akar1, 1Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, 2Pediatrics, Ege University School of Medicine, Izmir, Turkey

    Background/Purpose Familial Mediterranean fever (FMF) is an autosomal-recessive autoinflammatory disorder characterized by recurrent episodes of fever accompanied by sterile peritonitis. The most devastating complication of…
  • Abstract Number: 1214 • 2014 ACR/ARHP Annual Meeting

    Oxidative Stress from Use of Allopurinol – Is There a Reason for Patients with Gout to Take Vitamin C?

    Lisa K. Stamp1, Peter T. Chapman2, John L. O'Donnell3, Irada Khalilova4, Rufus Turner4 and Anthony Kettle4, 1Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand, 2Rheumatology, Immunology & Allergy, Christchurch Hospital, Christchurch, New Zealand, 3Rheumatology Immunology & Allergy, Canterbury Health Laboratories, Christchurch, New Zealand, 4Pathology, University of Otago, Christchurch, Christchurch, New Zealand

    Background/Purpose During acute gout attacks neutrophils are activated and release a number of pro-inflammatory cytokines and enzymes. One of these enzymes is myeloperoxidase (MPO), which…
  • Abstract Number: 1212 • 2014 ACR/ARHP Annual Meeting

    Behcets Disease in Females Due to Mutation in NEMO, the NF-Kb Essential Modulator

    Alex Wessel1, Spiros Vonortas2, Jevgenia Zilberman-Rudenko3, Richard Siegel4 and Eric Hanson5, 15814 Beech Ave, NIH, Bethseda, MD, 2NIH, NIAMS, Bethesda, MD, 3Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4NIAMS, NIH, Bethesda, MD, 5National Institute of Health, Bethesda, MD

    Background/Purpose: Behçet's disease (BD) is a chronic multi-system inflammatory disorder associated clinically with oral and genital ulceration, uveitis, erythema nodosum, and other inflammatory disease. The…
  • Abstract Number: 1213 • 2014 ACR/ARHP Annual Meeting

    Absence of Hormone Responsive Estrogen Receptor Alpha Reduces the Activation of Plasmacytoid Dendritic Cells in Lupus Prone Mice

    Jennifer L. Scott1, Melissa A. Cunningham2, Osama S. Naga3, Jackie G. Eudaly3, Jena R. Wirth4 and Gary S. Gilkeson5, 1Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, 2Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 3Medicine/Rheumatology, Medical University of South Carolina, Charleston, SC, 4Med/Rheumatology, MUSC, Charleston, SC, 5Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that affects women at a 9 to 1 ratio compared to men. To further understand…
  • Abstract Number: 1211 • 2014 ACR/ARHP Annual Meeting

    Gene Expression Profile in Muscle Tissue before and after Immunosuppressive Treatment in Patients with Myositis

    Joan Raouf1, Ingela M. Loell2, Yi-Wen Chen3, Rongye Shi4, Inger Nennesmo5, Helene Alexanderson6, Maryam Dastmalchi2, Marina Korotkova7, Kanneboyina Nagaraju8,9 and Ingrid E. Lundberg10,11, 1Department of Medicine, Rheumatology Unit, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 2Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, 3Research Center for Genetic Medicine, Children’s National Medical Center, Washington DC, USA., Washington DC, DC, 4Research Center for Genetic Medicine, Childrens National Medical Center, Research Center for Genetic Medicine, Washington DC, USA, Washington DC, WA, 5Institution for Laboratory Medicine (LABMED), Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden, Stockholm, Sweden, 6Karolinska Institutet, Department of medicine, Rheumatology Unit, Karolinska Universitetssjukhuset Solna, Stockholm, Sweden, Stockholm, Sweden, 7Department of Medicine, Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 8Genetic Medicine, Children's National Medical Center, Washinton D C, DC, 9Research Center for Genetic Medicine, Children’s National Medical Center, Washington DC, DC, 10Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, 11Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose Autoimmune muscle diseases such as polymyositis (PM) and dermatomyositis (DM) are characterized by infiltration of inflammatory cells, production of cytokines and chemokines, as well…
  • Abstract Number: 1210 • 2014 ACR/ARHP Annual Meeting

    The Role of the Transcription Factor cAMP Responsive Element Binding Protein 1 in Lipopolysaccharide-Induced Tolerance

    Kerstin Klein1, Renate E. Gay2, Christoph Kolling3, Lih-Ling Lin4, Steffen Gay1 and Caroline Ospelt1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland, 3Schulthess Clinic, Zurich, Switzerland, 4Inflammation and Remodeling Research Unit, Pfizer, Cambridge, MA

    Background/Purpose In macrophages, repeated stimulation of Toll-like receptor (TLR) 4 leads to adaptation of signaling pathways and epigenetic modifications resulting in a tolerant state of…
  • Abstract Number: 1209 • 2014 ACR/ARHP Annual Meeting

    Anti-Scavenger Receptor Autoantibodies Disrupted Marginal Zone Macrophage Integrity Via Bruton’s Tyrosine Kinase

    Hao Li1,2, Qi Wu1, PingAr Yang1, Zheng Wang3, Jun Li1, Bao Luo1, Jeffrey C. Edberg1, Hui-Chen Hsu1, John D. Mountz1,4 and Robert P. Kimberly on behalf of PROFILE investigators5, 1Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Department of Medicine, Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Med - Pulmonary/Allergy/Critical Care, University of Alabama at Birmingham, Birmingham, AL, 4Birmingham VA Medical Center, Birmingham, AL, 5Clinical Immun & Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose Ibrutinib, a Btk kinase activity inhibitor, is a novel inhibitor under development for autoimmune disease therapy.  We have shown that Btk was significantly upregulated…
  • Abstract Number: 1208 • 2014 ACR/ARHP Annual Meeting

    Cholesterol Loading Induces Neutrophil Extracellular Traps, and Atorvastatin Attenuates This Effect

    Ming-Lin Liu1,2, Muhammad Bashir1,3, Kevin Williams4 and Victoria Werth5,6, 1Department of Dermatology, University of Pennsylvania, Philadelphia, PA, 2Department of Dermatology,, Philadelphia V.A. Hospital, Philadelphia, PA, 3Department of Dermatology, Philadelphia V.A. Hospital, Philadelphia, PA, 4Department of Medicine, Temple University School of Medicine, Philadelphia, PA, 5Dermatology, University of Pennsylvania, Philadelphia, PA, 6Dermatology, Philadelphia V.A. Hospital, Philadelphia, PA

    Background/Purpose Neutrophils are the most common white blood cell, but their role in autoimmune and cardiovascular diseases has been underestimated. As part of host defense,…
  • Abstract Number: 1207 • 2014 ACR/ARHP Annual Meeting

    Novel Role of Liver X Receptor Alpha (LXRα) in the Attenuation of TLR Signalling: Implications in Congenital Heart Block

    Susmita Bagchi1, Mark Halushka2, Robert M. Clancy1 and Jill P. Buyon1, 1Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 2Division of Cardiovascular Pathology, John Hopkins Pathology, Baltimore, MD

    Background/Purpose:  Anti-SSA/Ro associated congenital heart block provides a unique opportunity to examine the effector arm of immunity and define the molecular mechanisms that link maternal…
  • Abstract Number: 1206 • 2014 ACR/ARHP Annual Meeting

    Low Dose Colchicine Anti-Inflammatory Effects Are Transduced By AMP-Activated Protein Kinase (AMPK)

    Ru Bryan1, Robert Terkeltaub2 and Yun Wang3, 1Medicine-Rheumatology, VA Medical Center/University of California San Diego, San Diego, CA, 2Medicine-Rheumatology, VA Medical Ctr/University of California San Diego, San Diego, CA, 3Medicine-Rheumatology, VA Medical Ctr/UCSD, San Diego, CA

    Background/Purpose AMPK is a master metabolic energy regulator, whose tissue activity drops in response to nutritional excesses, alcohol consumption, and in obesity, metabolic syndrome and…
  • Abstract Number: 1205 • 2014 ACR/ARHP Annual Meeting

    Expression of Lectin-like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis

    Paulina Chalan1, Johan Bijzet2, Minke G. Huitema3, Bart-Jan Kroesen4, Elisabeth Brouwer1 and Annemieke M.H. Boots1, 1Dept. of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Dept. of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose Precursor Th17 lineage cells expressing CD161 are implicated in rheumatoid arthritis (RA) pathogenesis. CD4+CD161+ T cells were found to accumulate in RA synovial fluid…
  • Abstract Number: 1204 • 2014 ACR/ARHP Annual Meeting

    Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NFkB Signaling and Macrophage Migration

    Nicholas A. Young1, Michael Bruss2, Mark Gardner3, William Willis3, Xiaokui Mo3, Giancarlo Valiente3, Yu Cao4, Zhongfa Liu4, Lai-Chu Wu1 and Wael N. Jarjour5, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 4Rheumatology and Immunology, The Ohio State University Wexner Medical Center, columbus, OH, 5Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: The major obstacles to successful use of curcumin as an anti-inflammatory agent are its low solubility in water and rapid metabolism, which both translate…
  • « Previous Page
  • 1
  • …
  • 2150
  • 2151
  • 2152
  • 2153
  • 2154
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology